Apogee Therapeutics, Inc. (APGE)
135.06
+0.08
(+0.06%)
USD |
NASDAQ |
Aug 31, 16:00
135.06
0.00 (0.00%)
After-Hours: 20:00
Apogee Therapeutics Net Income (TTM) : -294.37M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -294.37M |
| March 31, 2026 | -274.62M |
| December 31, 2025 | -255.84M |
| September 30, 2025 | -253.67M |
| June 30, 2025 | -237.67M |
| March 31, 2025 | -205.39M |
| December 31, 2024 | -182.15M |
| September 30, 2024 | -146.66M |
| Date | Value |
|---|---|
| June 30, 2024 | -118.48M |
| March 31, 2024 | -103.55M |
| December 31, 2023 | -83.98M |
| September 30, 2023 | -66.26M |
| June 30, 2023 | -65.07M |
| March 31, 2023 | -48.00M |
| December 31, 2022 | -39.78M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Cogent Biosciences, Inc. | -377.18M |
| Arrowhead Pharmaceuticals, Inc. | -272.12M |
| Intellia Therapeutics, Inc. | -399.98M |
| Revolution Medicines, Inc. | -1.768B |
| Erasca, Inc. | -287.22M |